|
Characteristics
|
FOXO3 expression status
|
|---|
|
Low (n = 71)
|
High (n = 32)
|
P
|
|---|
|
Gender
|
|
Male
|
60 (70.6%)
|
25 (29.4%)
|
0.430
|
|
Female
|
11 (61.1%)
|
7 (38.9%)
|
|
Age
|
|
<60
|
25 (71.4%)
|
10 (28.6%)
|
0.700
|
|
≥ 60
|
44 (67.7%)
|
21 (32.3%)
|
|
Tumor size
|
|
< 5 cm
|
41 (69.5%)
|
18 (30.5%)
|
0.899
|
|
≥ 5 cm
|
28 (68.3%)
|
13 (31.6%)
|
|
Tumor stage
|
|
T1+ T2
|
7 (58.3%)
|
5 (41.7%)
|
0.399
|
|
T3+ T4
|
64 (70.3%)
|
27 (29.7%)
|
|
Histological grade
|
|
Well/moderate
|
51 (68.0%)
|
24 (32.0%)
|
0.738
|
|
Poor/NS
|
20 (68.9%)
|
8 (28.6%)
|
|
Lymph node metastasisa
|
|
Negative
|
26 (56.5%)
|
20 (43.5%)
|
0.011
|
|
Positive
|
44 (80.0%)
|
11 (20.0%)
|
|
Clinical stagesa
|
|
I + II
|
22 (56.4%)
|
17 (43.6%)
|
0.026
|
|
III + IV
|
48 (69.3%)
|
14 (30.7%)
|
- aNumbers do not equal to the total number due to missing data
